30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Onyia Jude

Track

Insider profile

Performance

Overall performance
3.4
Performance over holding periods
3.4
30 days 90 days 120 days
Average return 42% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Onyia Jude's trades of Neurocrine Biosciences Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-02 2026-06-01
PlS Planned sale
81,377 +32.6%
179.63
US$1,372,356 		81,377 +32.6% 179.63 US$1,372,356
2026-06-01 2026-06-01
PrS Proposed sale
79,123
433.95
US$4,130,368 		79,123 433.95 US$4,130,368
2026-05-29 2026-05-27
PlS Planned sale
58,502 +37.7%
257.79
US$2,969,876 		58,502 +37.7% 257.79 US$2,969,876
2026-05-27 2026-05-27
PrS Proposed sale
11,000
155.73
US$1,713,030 		11,000 155.73 US$1,713,030
2025-07-11 2025-07-09
PlS Planned sale
59,819 -76.6%
130.46
US$7,803,688 		59,819 -76.6% 130.46 US$7,803,688
2025-07-07 2025-07-02
PlS Planned sale
20,362 -52.7%
130.13
US$2,649,738 		20,362 -52.7% 130.13 US$2,649,738
2025-07-02 2025-07-02
PrS Proposed sale
80,181
128.00
US$10,263,168 		80,181 128.00 US$10,263,168
2025-02-14 2025-02-13
PlS Planned sale
1,447 -7.4%
116.75
US$168,933 		1,447 -7.4% 116.75 US$168,933
2025-02-14 2025-02-13
PlS Planned sale
1,432 -7.8%
116.83
US$167,306 		1,432 -7.8% 116.83 US$167,306
2025-02-13 2025-02-13
PrS Proposed sale
1,447
117.18
US$169,559 		1,447 117.18 US$169,559
2025-02-13 2025-02-13
PrS Proposed sale
1,432
117.18
US$167,802 		1,432 117.18 US$167,802
2025-02-04 2025-01-31
PlS Planned sale
126 -0.8%
152.97
US$19,274 		126 -0.8% 152.97 US$19,274
2025-01-31 2025-01-31
PrS Proposed sale
126
153.29
US$19,315 		126 153.29 US$19,315
2024-12-03 2024-11-29
PlS Planned sale
2,331 -13.1%
126.29
US$294,373 		2,331 -13.1% 126.29 US$294,373
2024-11-29 2024-11-29
PrS Proposed sale
2,331
126.59
US$295,081 		2,331 126.59 US$295,081
2024-02-15 2024-02-13
PlS Planned sale
1,432 -9.8%
132.94
US$190,371 		1,432 -9.8% 132.94 US$190,371
2024-02-13 2024-02-13
PrS Proposed sale
1,432
130.43
US$186,776 		1,432 130.43 US$186,776
2024-02-02 2024-01-31
PlS Planned sale
126 -1.1%
141.94
US$17,884 		126 -1.1% 141.94 US$17,884
2024-01-31 2024-01-31
PrS Proposed sale
126
142.06
US$17,900 		126 142.06 US$17,900
2023-12-01 2023-11-29
PlS Planned sale
2,331 -16.6%
113.57
US$264,733 		2,331 -16.6% 113.57 US$264,733
2023-11-29 2023-11-29
PrS Proposed sale
2,331
112.84
US$263,030 		2,331 112.84 US$263,030
2023-08-22 2023-08-22
PrS Proposed sale
3,198
108.32
US$346,407 		3,198 108.32 US$346,407
2023-08-23 2023-08-21
PlS Planned sale
3,198 -24.9%
107.37
US$343,368 		3,198 -24.9% 107.37 US$343,368
2023-02-08 2023-02-07
PlS Planned sale
4,508 -40.9%
102.30
US$461,166 		4,508 -40.9% 102.30 US$461,166
2023-02-02 2023-01-31
PlS Planned sale
126 -4.8%
108.48
US$13,668 		126 -4.8% 108.48 US$13,668
2022-12-01 2022-11-29
PlS Planned sale
2,331 -49.6%
121.90
US$284,160 		2,331 -49.6% 121.90 US$284,160
2021-08-18 2021-08-18
B Purchase
400,000
0.25
£100,000 		400,000 0.25 £100,000